Mechanism of α1-Adrenergic Receptor-Induced Increased Contraction of Rat Mesenteric Artery in Aging Hypertension Rats
Authors:
- 22 March 2021
- journal article
- research article
- Published by S. Karger AG in Gerontology
- Vol. 67 (3) , 323-337
Abstract
Introduction: Vasoconstriction is triggered by an increase in intracellular-free calcium concentration. Growing evidence indicates that contraction is also regulated by calcium-independent mechanisms involving RhoA-Rho kinase (ROCK), protein kinase C (PKC), and so on. In this study, we studied the changes of vascular reactivity as well as the underlying signaling pathways in aging spontaneously hypertensive rats (SHRs). Methods: The artery tension induced by α1-adrenergic receptor activator (α1-AR) phenylephrine (PE) was measured in the absence or presence of myosin light chain kinase (MLCK), PKC, and ROCK inhibitors. The α1-AR, PKC, ROCK, phosphorylation of myosin light chain (MLC), and PKC-potentiated phosphatase inhibitors of 17 kDa (CPI-17) of rat mesenteric arteries were analyzed at the mRNA level or protein level. Results: The vascular tension measurements showed that there was a significant increase in the mesenteric artery contraction induced by PE in old SHR. MLCK inhibitor ML-7 can similarly inhibit PE-induced vasoconstriction. PKC inhibitor GF109203X has the weakest inhibitory effect on PE-induced contraction in old SHR. At the presence of ROCK inhibitor H1152, PE-induced contraction was significantly reduced in young Wistar-Kyoto (WKY) rats, but this phenomenon disappeared in other rats. Furthermore, in old SHR the protein expression of α1-AR decreased and phosphorylation of MLC and CPI-17 were upregulated and MLC phosphatase (MLCP) activity was significantly lower. The expressions of PKC were upregulated in SHR and old rats. In addition, the expression of ROCK-1 was decreased and ROCK-2 was significantly upregulated with age in SHR. Conclusion: In aging hypertension, the expression/activity of PKC or ROCK-2/CPI-17 excessively increased, MLCP activity decreased and MLC phosphorylation enhanced, leading to increased α1-AR-induced vasoconstriction.Keywords
This publication has 45 references indexed in Scilit:
- Protein Kinase C Inhibitors as Modulators of Vascular Function and Their Application in Vascular DiseasePharmaceuticals, 2013
- Protein kinase C, an elusive therapeutic target?Nature Reviews Drug Discovery, 2012
- The role of Rho protein signaling in hypertensionNature Reviews Cardiology, 2010
- ROCK Isoform Regulation of Myosin Phosphatase and Contractility in Vascular Smooth Muscle CellsCirculation Research, 2009
- Smooth muscle signalling pathways in health and diseaseJournal of Cellular and Molecular Medicine, 2008
- Anti-ischemic Effects of Fasudil, a Specific Rho-Kinase Inhibitor, in Patients With Stable Effort AnginaJournal of Cardiovascular Pharmacology, 2007
- Expression of CPI‐17 and myosin phosphatase correlates with Ca2+ sensitivity of protein kinase C‐induced contraction in rabbit smooth muscleThe Journal of Physiology, 2001
- Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertensionThe FASEB Journal, 2001
- Increased Ca2+ sensitivity of contractile elements via protein kinase C in α-toxin permeabilized SMA from young spontaneously hypertensive ratsCardiovascular Research, 1997
- Gamma-interferon corrects aberrant protein kinase C levels and immunosuppression in the spontaneously hypertensive ratInternational Journal of Immunopharmacology, 1992